Schematic representation of the molecular mechanism by which iRF decreases the aggressiveness of B16F10 cells. حسب Daisy Machado (288559)

الموضوعات:

NF/MNC injection at early time points post-MI decreases infarct size. حسب Ming-Yao Chang (700415)

Acute myocardial infarction changes bone marrow cell composition and decreases endothelial differentiation capability. حسب Ming-Yao Chang (700415)

"…<p><b>(A)</b> CD14 positive cells increased at day 1 post-MI while the CD16 positive cell decreased at day 4 and day 7 after infarction in <b>B</b> with n ≥3 per groups. …"

Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF حسب Rohit Moudgil (540119)

TLR4 expression decreases in B16-OVA tumors. حسب Andrés H. Rossi (739124)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. حسب Araceli Tobío (3545306)

Deletion of TXNIP decreases nitrative stress under normoxia and hyperoxia. حسب Mohammed A. Abdelsaid (287140)

Rdh10a deficient embryos have decreased RA signaling. حسب Enrico D’Aniello (798447)

Inhibition of TMEM16A decreased SW620 cell migration and invasion. حسب Yujie Sui (549090)

Gradual decreases in tyrosinase expression detected by Western blotting. حسب Shuji Nakamura (230936)

<b>Glucagon Clearance is Decreased in Chronic Kidney Disease, but Preserved in Liver Cirrhosis</b> حسب Magnus F. G. Grøndahl (19160825)

ShakB(N+16) increases, and ShakB(N) decreases, NB coupling. حسب Sami H. Jezzini (650703)

TMEM16A knockdown induced a decrease in proliferation of SW620 cells. حسب Yujie Sui (549090)

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons حسب Jiacheng Ma (1530640)

"…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …"

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons حسب Jiacheng Ma (1530640)

"…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …"

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons حسب Jiacheng Ma (1530640)

"…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …"

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons حسب Jiacheng Ma (1530640)

"…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …"

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons حسب Jiacheng Ma (1530640)

"…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …"

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. حسب Yunseo Woo (6157307)

Systemic inhibition of CSF-1R decreases B16F10-induced accumulation of blood monocyte subsets. حسب Marjolein Sluijter (613087)

الموضوعات: